Voyager Therapeutics, Inc. Other Non-Current Liabilities
Voyager Therapeutics, Inc. (VYGR) had Other Non-Current Liabilities of $37.50 million as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2025-03-11
- 2024-12-31: Other Liabilities, Noncurrent $37.50M.
- 2024-09-30: Other Liabilities, Noncurrent $39.37M.
- 2024-06-30: Other Liabilities, Noncurrent $41.20M.
- 2024-03-31: Other Liabilities, Noncurrent $43.00M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2024-12-31 | $37.50M 10-K · filed 2025-03-11 | |
| 2024-09-30 | $39.37M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $41.20M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $43.00M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $18.09M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $18.92M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $19.73M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $20.52M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $21.30M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $22.02M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $22.74M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $38.13M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $39.61M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $41.01M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $41.85M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $43.14M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $44.41M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $29.26M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $30.18M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $31.09M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $31.98M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $32.80M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $33.61M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $31.98M 10-Q · filed 2020-05-06 | $34.40M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $6.71M 10-K · filed 2020-03-03 | $1.00M 10-K · filed 2019-02-26 |
| 2018-09-30 | $1.00M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $1.01M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $1.01M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.01M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $1.01M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $1.02M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.02M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $25.00K 10-K · filed 2018-03-14 | |
| 2016-09-30 | $29.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $34.00K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $40.00K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $44.00K 10-K · filed 2017-03-15 | |
| 2015-09-30 | $52.00K 10-Q · filed 2015-12-17 | |
| 2014-12-31 | $255.00K 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |